AGGF1P9

Across TCGA pan-cancer cohorts, AGGF1P9 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated AGGF1P9 data layer.

The strongest signal is observed in thymoma (THYM), where higher AGGF1P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated AGGF1P9 expression acts as an unfavorable survival marker.

THYM, KIRC, and PAAD are the cancer types where AGGF1P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.169	0.931	<.001	81	view →
KIRC	DFS	Tertile	IV	0.106	0.640	<.001	36	view →
PAAD	OS	Tertile	All	0.302	0.617	.011	36	view →
ACC	OS	Tertile	All	0.214	0.820	.006	27	view →
BLCA	DFS	Tertile	III,IV	0.214	0.576	.013	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

AGGF1P9–THYM (OS)

Open the THYM breakdown →